Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVI-HBV-002 in chronic hepatitis B
NCT04289987Phase 2Completed
- Sponsor
- AriBio Lab
- Start
- Feb 2020
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CVI-HBV-002 in hepatitis B (HBV), sponsored by AriBio Lab. Started Feb 2020; status: completed.
02
Drugs
CVI-HBV-002
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04289987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289987.